1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use

US7566723B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Heike Gielen-Haertwig · Monheim, DE
• Volkhart Min-Jian Li · Velbert, DE
• Ulrich Rosentreter · Binnen, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Swen Allerheiligen · Wuppertal, DE
• Leila Telan · Wuppertal, DE
• Lars Bärfacker · Oberhausen, DE
• Jörg Keldenich · Wuppertal, DE
• Mary F. Fitzgerald · Yarnton, GB
• Kevin Nash · Seffner, US
• Barbara Albrecht · Wuppertal, DE
• Dirk Meurer · Wunstorf, DE

Key dates

• Filing date: Aug 28, 2003
• Grant date: Jul 28, 2009
• Expiry date: Mar 12, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to novel 1-Phenyl-3,4-dihydropyrimidin-2(1H)-one derivatives having the formula